Navigation Links
Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference
Date:3/1/2013

THOUSAND OAKS, Calif., March 1, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Cowen and Company 33rd Annual  Health Care Conference on Wednesday, March 6, 2013, at the Boston Marriott Copley Place, Boston, Mass., beginning at 9:20 a.m. EST. Arvind Sood , vice president of Investor Relations at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for 90 days following the event.

(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com. Follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Ashleigh Koss , 805-313-6151 (media)
Eric Hyllengren , 805-447-10
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... -- MEDITE Group acquired by CytoCore, Inc. (OTCBB: CYOE) on ... quarter sales ended September 30, 2014 of $8.7 million ... months ended September 2014 and a $38,000 loss for the ... quarter is usually a seasonable weak period due to the ... many countries worldwide, we are proud to announce record sales ...
(Date:11/22/2014)... DUBLIN , Nov. 21, 2014 Research ... "China Recombinant Protein Drug Industry Report, 2014-2017" report ... The Chinese recombinant protein drug market ... demand rigidity, consumption ability and the like. During 2005-2013, ... hospitals grew at a CAGR of 19.1%, and it ...
(Date:11/21/2014)... Mass. , Nov. 21, 2014  Alere Inc. ... rapid diagnostic tests, has appointed Juliet Cunningham ... role, Cunningham will be responsible for driving communications with ... execute on a series of changes to increase shareholder ... progress to investors," said Namal Nawana, Chief Executive Officer. ...
Breaking Medicine Technology:CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Alere Appoints Juliet Cunningham to Lead Investor Relations 2
... (Polaris) today announced that it has dosed the first ... lead cancer therapeutic, pegylated arginine deiminase (ADI-PEG 20), in ... cancers. These three cancers represent approximately 50% of all ... Patients with advanced cancers who have failed current therapy ...
... Inc. (Nasdaq: MSHL ), an oncology company ... cancer metabolism, announced today that Daniel P. Gold, Ph.D., ... on Marshall Edwards and the clinical development of its ... Roth Capital Partners Growth Stock Conference on Wednesday, March ...
Cached Medicine Technology:Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Pediatric Patients with Emphasis on Leukemia, Lymphoma and Sarcoma 2Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Pediatric Patients with Emphasis on Leukemia, Lymphoma and Sarcoma 3Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference 2
(Date:11/23/2014)... TX (PRWEB) November 23, 2014 ... market such as its significance, programs and manufacturing ... and Chinese suppliers major market gamers in information. ... information, item specifications, prospective, manufacturing value, and 2009-2014 ... research, the evaluation symbolizes the globally and Chinese ...
(Date:11/23/2014)... SWAccessControl.com's high quality access control power suppliers are popular ... its new collection of power suppliers. Additionally, it has ... suppliers. All the new models come with big discounts, ... Dec. 20, 2014. , SWAccessControl.com has thousands of happy ... for a long time. It is very wise to ...
(Date:11/23/2014)... AngelWeddingDress.com has recently updated its online store, ... dresses. “If you are looking for gorgeous beach wedding ... possible. Here you can enjoy 70% off discounts and ... a big marriage ceremony is the most important dream ... dress is uppermost priority. Ophelia, one of customers, said, ...
(Date:11/23/2014)... “BlackVue” was featured on NewsWatch as part of ... latest and coolest technology products available to consumers. Mallory ... the product review and shared with viewers how their ... car camera industry. , The need for in-car video ... find the one that’s right per consumer, especially considering ...
(Date:11/23/2014)... Columbus, OH (PRWEB) November 23, 2014 ... Schulte LLC on behalf of farmers and agribusinesses that ... Inc.’s attempts to commercialize Agrisure Viptera and Agrisure Duracade, ... have not been approved for sale in China. According ... caused China to virtually ban U.S. corn imports. Because ...
Breaking Medicine News(10 mins):Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2Health News:A Leader in Front and Rear Facing In-Car Cameras was Featured on NewsWatch Television on October 30, 2014 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3
... may help some cancer patients who have severe dry ... mainly patients with head and neck cancers treated with ... finger recuperated dry mouth in most of the patients. ... 2,000 years ago, acupuncture involves placing fine needles in ...
... showing great covenant in dental restorative work, say ... Technology at Ohio.//This ACP has new physical-chemical properties,” ... “It’s more soluble than other calcium phosphates and ... dental mineral hydroxyapatite, which is the main inorganic ...
... Changes in the human diet mean people today are more ... have said.Researchers at the University of Newcastle believe that changes ... it off its anti-cancer agents. ,The researchers are ... effective in fighting stomach cancer. They are carrying out two ...
... and palate are associated with permutation in brain structure ... study recently conducted by researchers at the University of ... facial clefts and 54 male control subjects, the researchers ... tissue composition. They found that the volume of the ...
... emitted by power plants and vehicles raises the risk ... dying from lung cancer or heart disease//, and the ... contend that simply living in a major urban area ... way into your lungs when you breathe, increasing your ...
... and Drug Administration has avowed Biolase Technology of San Clemente, ... root canal procedures on hard and soft tissue.//,The approval is ... and covers all enamel, dentin and pulpal removal as well ... a direct laser, the but alternatively furnishes optical energy ...
Cached Medicine News:Health News:Acupuncture to bring relief to patients with dry mouth 2
... Bright and playful, ... is perfect for girls ... fun.Trendy shapes, colorful accents ... flare to this exciting ...
... man. Includes an opthalmic collection that is ... a sunglass collection that will soon be ... divided into two parts named "Jhane Barnes ... use ophthalmic styles using cutting edge technology ...
... Thalia eyeglasses eyewear collection reflects ... of the renowned Latin singer/actress ... eyeglasses eyewear is ultra-sleek, fashionable, ... styles that include decorative details ...
... Silhouette has put together a remarkable ... . This collection combines all of the ... screwless and hingeless designs with top quality ... B and C radiation protection. They provide ...
Medicine Products: